Shortwave Infrared Surgical Imaging Device Study
Tissue Recognition and Depth-Sensing With A.I. Powered Hyperspectral Confocal Shortwave Infrared Imaging
1 other identifier
observational
50
1 country
6
Brief Summary
The goal of this observational study is to perform an in-human assessment of an investigational shortwave infrared (SWIR) imaging device, aimed to enhance the visualization of critical anatomical structures during surgical procedures in non-vulnerable adults between the ages of 18 and 70+. The main questions are to 1) evaluate the feasibility of utilizing SWIR imaging technology within a clinical environment, 2) ascertain the safety of the device, ensuring that its application does not interfere with or alter the established standard of care, and (3) collect preliminary human data that will inform and support the design of future research investigations. It is not the goal of this study to deviate from the standard of care, nor will it influence the diagnostic or therapeutic decisions made by the clinical team. The central hypothesis of this study is that shortwave infrared (SWIR) imaging will effectively visualize critical anatomical structures, such as nerves, ureters, and bile ducts, in human subjects. This expectation is grounded in favorable preclinical results observed in porcine models and cadaveric studies. Additionally, the investigators aim to demonstrate that the use of SWIR imaging can be accomplished without introducing additional risks to patients or disrupting established surgical workflows. After study subjects have consented, the participating surgeons will use the imaging device to visualize key structure seen during the procedure for no more than 10 minutes per case. The surgeons are also asked to complete a device assessment for each case.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Shorter than P25 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2026
CompletedFirst Submitted
Initial submission to the registry
July 26, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 11, 2026
August 4, 2026
July 1, 2026
5 months
July 26, 2026
July 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Type of structures identified
Anatomic structures seen through the device during surgery
May 29, 2026 to October 11, 2026
Secondary Outcomes (1)
Qualitative assessment of device functionality and performance by surgeons
May 29, 2026 to October 11, 2026
Study Arms (1)
FIH Cohort
Non-vulnerable adults (ages 18+)
Interventions
SWIR surgical imaging device to help surgeons visualize key structures during procedures
Eligibility Criteria
Adult patients, excluding vulnerable populations, undergoing surgeries who are able to provide voluntary, informed consent.
You may qualify if:
- Non-vulnerable adults
You may not qualify if:
- Vulnerable adults who are not able to provide voluntary, informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cision Vision, Inc.lead
- Stanford Universitycollaborator
- Johns Hopkins Universitycollaborator
- Endeavor Healthcollaborator
- University of Notre Damecollaborator
- Massachusetts Institute of Technologycollaborator
Study Sites (6)
Stanford Health Care
Palo Alto, California, 94304, United States
Endeavor Health - Evanston Hospital
Evanston, Illinois, 60035-2558, United States
Endeavor Health - Glenbrook Hospital
Glenview, Illinois, 60026, United States
Endeavor Health - Highland Park Hospital
Highland Park, Illinois, 60035-2558, United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
Johns Hopkins Hospital
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa M. Knowlton, MD, MPH
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2026
First Posted
August 4, 2026
Study Start
May 29, 2026
Primary Completion (Estimated)
October 11, 2026
Study Completion (Estimated)
October 11, 2026
Last Updated
August 4, 2026
Record last verified: 2026-07